Pipeline

R&D

Pipeline
Class Target Pipeline Indication/
Application
Discovery (Hit/lead/candidate) Pre clinical clinical
Antibodies
(Tomaralimab)
TLR2 NM-101
NM-102
PD/AD
Antibodies
(Novel)
TLR2 NM-201 NM-202
BBB penetrating antibody BBB NM-301 Brain delivery
Small molecule αSyn aggregate NM-401
NM-402
NM-403
PD
MSA
DLB
Diagnosis αSyn aggregate NM-501 PD
Neuramedy Co.,Ltd
Room 301, NaRin Building, 215-6, Yulgok-ro, Jongno-gu, Seoul, 03100, South Korea
Tel : +82-2-765-3344 | E-mail : contact@neuramedy.com

COPYRIGHT © Neuramedy Co.,Ltd ALL RIGHT RESERVED